Trade Mark Journal No.2026/001 2 January 2026

WO0000001879312 (42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:4 June 2025
Date of designation in the UK: 4 June 2025
Image for mark 1879312_TIF CoreMetabolomics by Nightingale Health

International priority date claimed: 19 December 2024 (European Union Intellectual Property Office (EUIPO)) (019122331)
Class 42
Medical research; laboratory services; medical research laboratory services; biomedical research services; blood analysis services; blood analysis services for scientific research purposes; biofluid analysis services; biofluid analysis services for scientific research purposes; provision of online non-downloadable web-based software applications for collecting, measuring, analysing, monitoring and reporting health condition data as well as physiological and biosignal data; consultancy relating to laboratory testing; rental of laboratory apparatus and instruments; information, consultancy and advisory services relating to all of the aforementioned services.
Class 44
Laboratory analysis services relating to the treatment of persons; blood test services; medical laboratory services for the analysis of blood and biofluid samples taken from patients; conducting screenings for disease risk factors; collection and preservation of human blood; providing medical information; preparation of medical reports relating to health care and wellbeing; providing medical information and health and bodily wellbeing information to patients, consumers, and medical professionals by means of preparation of reports relating to health care matters; information, consultancy and advisory services relating to all of the aforementioned services.

Nightingale Health Oyj

Representative: PAPULA OY, Mechelininkatu 1 a, FI-00180 Helsinki, FINLAND